Ibuprofeno Aurovitas

Ibuprofen, the active ingredient in Ibuprofeno Aurovitas, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It is employed to relieve mild to moderate pain, reduce fever, and manage inflammatory conditions in adults and children when appropriate.

GNH USA supplies Ibuprofeno Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that acts on inflammatory and pain pathways, making it useful for several common conditions. - Mild to moderate pain: Provides analgesic relief for headaches, dental pain, musculoskeletal aches, and postoperative discomfort. - Fever: Reduces elevated body temperature associated with infections or inflammatory states. - Osteoarthritis and rheumatoid arthritis: Decreases joint pain and swelling, improving mobility. - Dysmenorrhea: Alleviates menstrual cramps and associated discomfort.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated blood pressure in susceptible individuals.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding, which can be life‑threatening. - Severe renal impairment or acute kidney injury, especially with dehydration. - Anaphylactic or severe allergic reactions, including angioedema. - Hepatotoxicity presenting as jaundice or abnormal liver enzymes. - Hematologic abnormalities such as thrombocytopenia or leukopenia.

Before initiating therapy, consider the following safety measures. - Assess renal function: avoid use in patients with severe renal impairment. - Evaluate gastrointestinal risk: use caution in individuals with a history of ulcers or bleeding. - Monitor cardiovascular status: patients with hypertension or heart disease may need closer observation. - Review concomitant medications: avoid combining with other NSAIDs or anticoagulants without medical guidance. - Pregnancy and lactation: consult a healthcare professional before use during pregnancy or breastfeeding. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Ibuprofen can affect the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - High‑dose aspirin: heightened renal and gastrointestinal adverse effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in volume‑depleted patients. - Diuretics: potential for reduced efficacy and renal impairment. - Lithium: ibuprofen can raise lithium levels, risking toxicity.